Stock Events

Stock Events

Anthera Pharmaceuticals 

$0
9
-$0-99% Thursday 16:35

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
23,894
Avg. Volume
2,726
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

18NovExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2024
Q2 2024
Q3 2024
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2012
2013
2014
2015
2016
2017
0Revenue
-26.87MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ANTH. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company that develops and manufactures innovative human therapeutics, including treatments in areas that may overlap with Anthera's focus on autoimmune and inflammatory diseases.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in similar therapeutic areas as Anthera, including immunology and oncology, making it a direct competitor in the biopharmaceutical market.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company with a strong portfolio in cardiovascular, oncology, and immune science, competing in the same space as Anthera.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, including treatments that could be in direct competition with Anthera's products.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation with a broad range of products in various therapeutic areas, including those that compete with Anthera's focus areas.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of treatments for serious medical conditions, potentially competing with Anthera in the biotech space.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is known for creating transformative medicines for people with serious diseases, including cystic fibrosis, which may compete with Anthera's therapeutic areas.
Biogen
BIIB
Mkt Cap22.63B
Biogen is a biotechnology company that develops therapies for neurological and neurodegenerative diseases, potentially overlapping with Anthera's interest in autoimmune diseases.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including those in areas competing with Anthera.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including in areas that may compete with Anthera's product pipeline.

About

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.
Show more...
CEO
Mr. Paul F. Truex M.B.A.
Employees
21
Country
US
ISIN
US03674U3005

Listings

OTC Link
US
ANTH

0 Comments

Share your thoughts

FAQ

What is Anthera Pharmaceuticals stock price today?▼
The current price of ANTH is $0 USD — it has decreased by -99% in the past 24 hours. Watch Anthera Pharmaceuticals stock price performance more closely on the chart.
What is Anthera Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Anthera Pharmaceuticals stocks are traded under the ticker ANTH.
What is Anthera Pharmaceuticals revenue for the last year?▼
Anthera Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Anthera Pharmaceuticals net income for the last year?▼
ANTH net income for the last year is -26.87M USD.
How many employees does Anthera Pharmaceuticals have?▼
As of April 03, 2026, the company has 21 employees.
In which sector is Anthera Pharmaceuticals located?▼
Anthera Pharmaceuticals operates in the Health Care sector.
When did Anthera Pharmaceuticals complete a stock split?▼
The last stock split for Anthera Pharmaceuticals was on May 01, 2017 with a ratio of 1:8.
Where is Anthera Pharmaceuticals headquartered?▼
Anthera Pharmaceuticals is headquartered in Houston, US.